Media Coverage

Media Coverage

Read how Vistagen’s intention to revolutionize mental health medicine is causing a buzz in the media.

The Deal
VistaGen Working on Oral Ketamine-like Compound for Depression
Read
Outsourcing-Pharma logo image
Two US patents will help deliver ketamine-like antidepressant effects, says VistaGen
Read
Business Insider logo image
A depression drug that researchers have called 'the most important discovery in half a century' just got a big lift
Read
Business Insider logo image
Pharma giants are looking to ketamine for clues to the next blockbuster depression drug — and science says they're onto something big
Read
Chemistry World logo image
The K factor: How the party drug ketamine may hold the key to treating patients with severe depression
Read
Forbes logo image
Street Gets More Bullish On Allergan As It Sees Solid Growth Ahead
Read